Corrigendum: Cross-reactive humoral and CD4+ T cell responses to Mu and Gamma SARS-CoV-2 variants in a Colombian population

Fabiola Martel; Juliana Cuervo-Rojas; Juana Ángel; Beatriz Ariza; John Mario González; Carolina Ramírez-Santana; Yeny Acosta-Ampudia; Luisa Murcia-Soriano; Norma Montoya; Claudia Cecilia Cardozo-Romero; Sandra Liliana Valderrama-Beltrán; Magda Cepeda; Julio César Castellanos; Carlos Gómez-Restrepo; Federico Perdomo-Celis; Andreu Gazquez; Alexandria Dickson; James D Brien; José Mateus; Alba Grifoni; Alessandro Sette; Daniela Weiskopf; Manuel A Franco

doi:10.3389/fimmu.2023.1274753

Corrigendum: Cross-reactive humoral and CD4⁺ T cell responses to Mu and Gamma SARS-CoV-2 variants in a Colombian population

Front Immunol. 2023 Aug 16:14:1274753. doi: 10.3389/fimmu.2023.1274753. eCollection 2023.

Authors

Fabiola Martel¹, Juliana Cuervo-Rojas², Juana Ángel¹, Beatriz Ariza³, John Mario González⁴, Carolina Ramírez-Santana⁵, Yeny Acosta-Ampudia⁵, Luisa Murcia-Soriano⁶, Norma Montoya⁷, Claudia Cecilia Cardozo-Romero³, Sandra Liliana Valderrama-Beltrán⁸, Magda Cepeda², Julio César Castellanos⁹, Carlos Gómez-Restrepo², Federico Perdomo-Celis¹, Andreu Gazquez¹⁰, Alexandria Dickson¹⁰, James D Brien¹⁰, José Mateus¹¹, Alba Grifoni¹¹, Alessandro Sette^{11

12}, Daniela Weiskopf¹¹, Manuel A Franco¹

Affiliations

¹ Institute of Human Genetics, School of Medicine, Pontificia Universidad Javeriana, Bogotá, Colombia.
² Department of Clinical Epidemiology and Biostatistics, School of Medicine, Pontificia Universidad Javeriana, Bogotá, Colombia.
³ Clinical Laboratory Science Research Group, Clinical Laboratory, Hospital Universitario San Ignacio, Bogotá, Colombia.
⁴ Group of Basic Medical Sciences, School of Medicine, Universidad de Los Andes, Bogotá, Colombia.
⁵ Center for Autoimmune Diseases Research (CREA), School of Medicine and Health Sciences, Universidad del Rosario, Bogotá, Colombia.
⁶ Hospital Universitario Mayor-Méderi, Universidad El Rosario, Bogotá, Colombia.
⁷ Head Clinical Laboratory Unit, Clínica del Occidente, Bogotá, Colombia.
⁸ Division of Infectious Diseases, Department of Internal Medicine. School of Medicine, Pontificia Universidad Javeriana, Hospital Universitario San Ignacio Infectious Diseases Research Group, Bogotá, Colombia.
⁹ General Direction, Hospital Universitario San Ignacio, Bogotá, Colombia.
¹⁰ Department of Molecular Microbiology and Immunology, Saint Louis University School of Medicine, St. Louis, MO, United States.
¹¹ Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, United States.
¹² Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego, La Jolla, CA, United States.

Abstract

[This corrects the article DOI: 10.3389/fimmu.2023.1241038.].

Keywords: CD4+ T cell; SARS-CoV-2; antibody; breakthrough infections; hybrid immunity; natural infection; vaccination; variants.

Copyright © 2023 Martel, Cuervo-Rojas, Ángel, Ariza, González, Ramírez-Santana, Acosta-Ampudia, Murcia-Soriano, Montoya, Cardozo-Romero, Valderrama-Beltrán, Cepeda, Castellanos, Gómez-Restrepo, Perdomo-Celis, Gazquez, Dickson, Brien, Mateus, Grifoni, Sette, Weiskopf and Franco.

Publication types

Published Erratum